This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...
A weekly injection is no longer the only way to reap the obesity management and weight loss benefits of glucagon-like peptide-1 (GLP-1) medications. The U.S. Food and Drug Administration (FDA) has ...
The weight loss drugs landscape in the UK underwent a seismic shift on 6 July 2026 when Wegovy – an injectable semaglutide – ...
The Wegovy weight loss pill is the UK's first GLP-1 weight-loss tablet and offers patients a new alternative to weekly weight-loss injections ...
Gone are the days when the somewhat painful jabs used to be the only option to battle obesity. People in the UK finally have an alternative to weekly weight-loss injections. Now, instead of needles, ...
The once-a-day pill, from the makers of the Wegovy weight-loss jab, can now be bought privately in UK pharmacies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results